Logo image of GENM.CA

GENERATION MINING LTD (GENM.CA) Stock Fundamental Analysis

TSX:GENM - Toronto Stock Exchange - CA37149B1094 - Common Stock - Currency: CAD

0.37  +0.02 (+4.23%)

Fundamental Rating

1

Taking everything into account, GENM scores 1 out of 10 in our fundamental rating. GENM was compared to 805 industry peers in the Metals & Mining industry. GENM has a bad profitability rating. Also its financial health evaluation is rather negative. GENM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GENM had negative earnings in the past year.
In the past year GENM has reported a negative cash flow from operations.
GENM had negative earnings in each of the past 5 years.
GENM had a negative operating cash flow in each of the past 5 years.
GENM.CA Yearly Net Income VS EBIT VS OCF VS FCFGENM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

GENM has a worse Return On Assets (-455.08%) than 86.46% of its industry peers.
Industry RankSector Rank
ROA -455.08%
ROE N/A
ROIC N/A
ROA(3y)-190.5%
ROA(5y)-166.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GENM.CA Yearly ROA, ROE, ROICGENM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GENM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GENM.CA Yearly Profit, Operating, Gross MarginsGENM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, GENM has more shares outstanding
Compared to 5 years ago, GENM has more shares outstanding
The debt/assets ratio for GENM is higher compared to a year ago.
GENM.CA Yearly Shares OutstandingGENM.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
GENM.CA Yearly Total Debt VS Total AssetsGENM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

GENM has an Altman-Z score of -42.11. This is a bad value and indicates that GENM is not financially healthy and even has some risk of bankruptcy.
GENM has a Altman-Z score of -42.11. This is in the lower half of the industry: GENM underperforms 79.01% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -42.11
ROIC/WACCN/A
WACCN/A
GENM.CA Yearly LT Debt VS Equity VS FCFGENM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

2.3 Liquidity

GENM has a Current Ratio of 1.59. This is a normal value and indicates that GENM is financially healthy and should not expect problems in meeting its short term obligations.
GENM's Current ratio of 1.59 is in line compared to the rest of the industry. GENM outperforms 51.43% of its industry peers.
A Quick Ratio of 1.59 indicates that GENM should not have too much problems paying its short term obligations.
GENM has a Quick ratio of 1.59. This is comparable to the rest of the industry: GENM outperforms 53.66% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
GENM.CA Yearly Current Assets VS Current LiabilitesGENM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

GENM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.95%.
EPS 1Y (TTM)-35.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-76.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 100.00% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y66.67%
EPS Next 2Y29.1%
EPS Next 3Y100%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GENM.CA Yearly EPS VS EstimatesGENM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GENM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GENM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GENM.CA Price Earnings VS Forward Price EarningsGENM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GENM.CA Per share dataGENM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

GENM's earnings are expected to grow with 100.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.1%
EPS Next 3Y100%

More info and screens

0

5. Dividend

5.1 Amount

GENM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENERATION MINING LTD

TSX:GENM (7/16/2025, 7:00:00 PM)

0.37

+0.02 (+4.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-11 2025-08-11
Inst Owners0.64%
Inst Owner ChangeN/A
Ins Owners6.34%
Ins Owner ChangeN/A
Market Cap99.23M
Analysts82.86
Price Target1.02 (175.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)100%
PT rev (3m)100%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS-0.21
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -455.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-190.5%
ROA(5y)-166.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z -42.11
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2.85%
Cap/Depr(5y)7.71%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-76.43%
EPS Next Y66.67%
EPS Next 2Y29.1%
EPS Next 3Y100%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.57%
EBIT Next 3Y8.74%
EBIT Next 5YN/A
FCF growth 1Y72.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y73.04%
OCF growth 3YN/A
OCF growth 5YN/A